Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis

Background: Renal impairment is one of the common characteristics of multiple myeloma (MM) and makes management of MM more complicated. Even though monoclonal antibodies targeting CD38 have wildly succeeded in treating MM, the addition of anti-CD38 monoclonal antibodies to standard therapy to treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Hexiang Bai, Chunlan Zhang, Ailin Zhao, Wenjiao Tang, Li Zhang
Format: Article
Language:English
Published: SAGE Publishing 2025-02-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207251319593
Tags: Add Tag
No Tags, Be the first to tag this record!